Clinical Trial Update: Multi-day Doses in Prevention of Nausea and Emesis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating multi-day dosing to prevent nausea and emesis in patients with multiple myeloma and lymphoma. The study completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Myeloma, Plasma-Cell, Lymphoma, Malignant | Phase 2 | Status: COMPLETED | Results posted: 2017-03-09